Affiliation:
1. Department of Internal Medicine, University of Ilorin Teaching Hospital, University street, Ilorin, Kwara, Nigeria
2. Department of Medicine, University College Hospital, Ibadan, Nigeria,
Abstract
Objectives
Type 2 diabetes is a chronic metabolic disorder characterised by elevated blood glucose levels due to insulin resistance or insufficient insulin production. Understanding the prevalence, characteristics, and markers of this disease is essential for effective prevention, management and treatment. The study aims to explore the association between type 2 diabetes and its prevalence, characteristics and markers.
Material and Methods
Adults with type 2 diabetes and matched healthy controls were enrolled in the study. Statistical calculations were used to establish the sample size. Information on demographics, physical examinations and lab tests were collected. We assessed plasma glucose, glycated haemoglobin (HbA1c), serum lipids and serum DPP4.
Results
The mean age (SD) of the population under research was 55.7 (6.12) years for the study subjects and 55.7 (6.11) years for the controls. A positive family history of diabetes was present in 34 (or 33%) of the diabetes patients compared to 11 (or 11%) of the non-diabetic patients (p 0.001). The mean HbA1c in the diabetic group was substantially greater than that of the non-diabetic controls (5.47 1.89%), as expected (7.23 2.69%), p 0.001. It’s interesting to note that total cholesterol was markedly higher in the diabetes participants (5.59 2.24 mmol/L) than in the non-diabetic controls (6.48 1.54 mmol/L), p = 0.001.
Conclusion
Due to common risk factors and underlying mechanisms, type 2 diabetes and hypertension may be related, as suggested by the high prevalence of hypertension in the diabetic group. Type 2 diabetes was substantially related to elevated HbA1c and fasting plasma glucose levels, indicating poor glycaemic control. The higher mean serum Dipeptidyl peptidase-4 (DPP4) level in the group with type 2 diabetes shows a link between high DPP4 levels and the disease, which may have an effect on incretin hormone activity, insulin resistance and therapeutic options.
Reference48 articles.
1. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030;Wild;Diabetes Care,2004
2. Socioeconomic position at three points in life in association with type 2 diabetes and impaired glucose tolerance in middle-aged Swedish men and women;Agardh;Int J Epidemiol,2011
3. Heterogeneity in Type 2 Diabetes: Predisposition, Complications, and Mortality;Schöttker;Diabetes Spectrum,2013
4. Gender Differences in Type 2 Diabetes Mellitus and Factors Related to Patient Delays in Seeking Care;Bae;Gender Medicine,2017
5. Diabetes Associated with a Novel Mutation in the KCNJ11 Gene: Extending the Clinical Spectrum of Mutations to Transient Neonatal Diabetes and Beyond;Murea;Diabetes,2018